Reaction Details Report a problem with these data
Target
Uracil-DNA glycosylase
Ligand
BDBM208037
Substrate
n/a
Meas. Tech.
Viral Plaque Reduction Assay
Temperature
310.15±n/a K
IC50
39000±n/a nM
Comments
extracted
Citation
 Ricciardi, RP; Nuth, M Potent poxvirus inhibitor US Patent  US9233921 Publication Date 1/12/2016 
Target
Name:
Uracil-DNA glycosylase
Synonyms:
OPG116 | UNG | UNG_VACCC | vaccinia virus D4/A20
Type:
n/a
Mol. Mass.:
25083.53
Organism:
Vaccinia virus (strain Copenhagen) (VACV)
Description:
P20536
Residue:
218
Sequence:
MNSVTVSHAPYTITYHDDWEPVMSQLVEFYNEVASWLLRDETSPIPDKFFIQLKQPLRNKRVCVCGIDPYPKDGTGVPFESPNFTKKSIKEIASSISRLTGVIDYKGYNLNIIDGVIPWNYYLSCKLGETKSHAIYWDKISKLLLQHITKHVSVLYCLGKTDFSNIRAKLESPVTTIVGYHPAARDRQFEKDRSFEIINVLLELDNKVPINWAQGFIY
  
Inhibitor
Name:
BDBM208037
Synonyms:
Methyl 3-((4-chlorophenyl)thio)-1-ethyl-5-methyl-1H-indole-2-carboxylate | US9233921, 5
Type:
Small organic molecule
Emp. Form.:
C19H18ClNO2S
Mol. Mass.:
359.87
SMILES:
CCn1c(C(=O)OC)c(Sc2ccc(Cl)cc2)c2cc(C)ccc12
Structure:
Search PDB for entries with ligand similarity: